✦ LIBER ✦

Prospective Randomized Trial of External Versus Internal Transcatheter Cardioversion in Patients with Chronic Atrial Fibrillation

✍ Scribed by K.E. Paravolidakis; T.M Kolettis; G.N. Theodorakis; I.A. Paraskevaidis; T.S. Apostolou; D.Th. Kremastinos

Book ID: 110279449
Publisher: Springer
Year: 1998
Tongue: English
Weight: 116 KB
Volume: 2
Category: Article
ISSN: 1383-875X
DOI: 10.1023/a:1009732903788

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Evaluation of Atrial Refractoriness and

Evaluation of Atrial Refractoriness and Atrial Fibrillation Inducibility Immediately after Internal Cardioversion in Patients with Chronic Persistent Atrial Fibrillation

✍ Giuseppe Boriani; Mauro Biffi; Romano Zannoli; Angelo Branzi; Bruno Magnani 📂 Article 📅 1999 🏛 Springer US 🌐 English ⚖ 87 KB

Improved Clinical Efficacy of External C

Improved Clinical Efficacy of External Cardioversion by Fluoroscopic Electrode Positioning and Comparison to Internal Cardioversion in Patients with Atrial Fibrillation

✍ ALI A. MEHDIRAD; KELLEY L. CLEM; CHARLES J. LOVE; STEVEN D. NELSON; STEPHEN F. S 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 374 KB

A Study of Fecal Incontinence in Patient

A Study of Fecal Incontinence in Patients with Chronic Anal Fissure: Prospective, Randomized, Controlled Trial of the Extent of Internal Anal Sphincter Division During Lateral Sphincterotomy

✍ Magdy M. A. Elsebae 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 121 KB

High dose chlorambucil versus Binet's mo

High dose chlorambucil versus Binet's modified cyclophosphamide, doxorubicin, vincristine, and prednisone regimen in the treatment of patients with advanced B-cell chronic lymphocytic leukemia : Results of an international multicenter randomized trial

✍ Branimir Jaksic; Maura Brugiatelli; Ivo Krc; Hajna Losonczi; Jerzy Holowiecki; A 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 115 KB 👁 2 views

vanced and/or progressive disease was defined by high Total Tumor Mass (TTM) score (ú9), and/or short doubling time (DT) (õ12 months), and/or bone marrow for the International Society for Chemo-Immunotherapy, Vienna failure. The response to therapy was defined by reduction of the initial TTM score.